September 23, 2019
  • September 23, 2019
Breaking News
  • Home
  • Markets
  • Incyte Corporation (NASDAQ:INCY) will receive an upfront payment of $17.5 million as part of license agreement with Zai Lab Ltd

Incyte Corporation (NASDAQ:INCY) will receive an upfront payment of $17.5 million as part of license agreement with Zai Lab Ltd

By on July 2, 2019 0

Incyte Corporation (NASDAQ:INCY) said Tuesday it will receive an upfront payment of $17.5 million as part of a license agreement with Zai Lab Ltd. for the development and commercialization of Incyte’s cancer treatment INCMGA0012 in China. Under terms of the agreement, Incyte is eligible to receive up to an additional $60 million in milestone payments, as well as tiered royalty payments from the “low to mid-twenties.”

The insider ownership percentage is the key indicator, can be used by investors, to measure the outlook of senior management has on their company. Insider ownership for the INCY is 0.40%. Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. The Institutional ownership for the INCY is 94.70%.

Insider trading is the buying or selling of any publicly traded company’s stock and this can be done by someone who has non-public, material information about that INCY. Insider trading can be illegal or legal depending on when the insider makes the trade. It is illegal when the material information is still non-public. The insider transactions of the company (6-month change in insider ownerships) for the Incyte Corporation (NASDAQ:INCY) is -11.75%.

[finviz ticker=INCY]

Institutional ownership is the amount of a Incyte Corporation (NASDAQ:INCY)’s available stock owned by mutual or pension funds, insurance companies, investment firms, private foundations, endowments or other large entities that actually manage the funds on the behalf of others, so its an interesting element for the traders to note it, and the Institutional ownership for the INCY is 0.49%.

a Healthcare sector firm, Incyte Corporation (NASDAQ:INCY) stock gained 0.54% on Monday and when day-trade ended the stock finally concluded at $85.42 and number of shares that changed hands during the day are 1.03 Million. The number of shares INCY stock currently held by all its shareholders are 213.83 and floated shares, the number of shares are available for trading in an open market on last trading day are 213.19. The average volume of shares for 3 months is 1372.41 and INCY stock value has moved between $56.95 – 88.98 in last one year.

The Incyte Corporation (NASDAQ:INCY)’s latest earnings date is 7/30/2019. The Gross margin is the difference between the revenue and the cost of goods sold (COGS), divided by revenue. In other words, Gross Margin is a percentage value, while Gross Profit is a monetary value. The valuable gross margin for Incyte Corporation (NASDAQ:INCY) is 96.10% and the profit margin is 12.70% and the stock has gained 34.33% in 2019 to date.

U.S. traded shares of Incyte Corporation (NASDAQ:INCY)’s monthly stock performance is 8.64%, the quarterly performance is -0.62%, the half year performance is calculated as 37.15%. The yearly performance of INCY is 29.90%.

The higher the volatility, the riskier the security. For example, when the stock market rises and falls more than one percent over a sustained period of time, it is called a “volatile” market, if the stock price stays relatively stable, the security has low volatility. The Incyte Corporation (NASDAQ:INCY) weekly volatility is measured as 2.65% and monthly volatility measured as 2.95%.

Return on assets (ROA) is a main indicator of how profitable a company is relative to its total assets. INCY return on assets is 9.80%, the return on equity (ROE) of the Incyte Corporation (NASDAQ:INCY) is 13.40%, while the most important return on investment is calculates as a percentage and is typically used for personal financial decisions, and INCY return on investment is 6.30%.

The price to earnings ratio is 73.01, price to sales ratio is 9.14, and price to book ratio is 8.77, price to cash per share ration is 11.55, price to free cash flow is 46.61.

Analysts mean target price for Incyte Corporation (NASDAQ:INCY) is $88.07 while analysts mean recommendation is 2.40. The current share price indicates that stock is -4.34% away from its one year high and is moving 49.86% ahead of its 52-week low. INCY’s distance from 20 day simple moving average is 4.10% and distance from 50-Day simple moving average is 7.02%.



  Markets
Leave a comment